Kewaunee Scientific Corporation (KEQU)

Kewaunee Scientific Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year	2024	2023	2022	2021	2020
Cash & Equivalents	25.94	13.82	6.89	5.73	5.22
Short-Term Investments	0	0	13.46	0	0
Cash & Cash Equivalents	25.94	13.82	20.35	5.73	5.22
Cash Growth	87.75%	-32.12%	255.10%	9.89%	-53.25%
Receivables	45.06	46.08	41.25	32.88	28.06
Inventory	20.68	21.89	23.8	16.52	15.33
Other Current Assets	5.14	6.14	6.16	5.33	5.62
Total Current Assets	96.82	87.92	91.57	60.46	54.23
Property, Plant & Equipment	25.1	25.57	22.69	25.26	25.58
Other Long-Term Assets	12.85	5.41	4.51	3.67	4.11
Total Long-Term Assets	37.95	30.98	27.21	28.93	29.7
Total Assets	134.77	118.9	118.77	89.38	83.93
Accounts Payable	23.26	23.6	27.32	16.78	13.11
Deferred Revenue	4.37	4.1	3.53	3.12	2.51
Current Debt	6.05	6.28	3.61	8.2	6.02
Other Current Liabilities	7.1	6.08	7.84	6.08	5.42
Total Current Liabilities	40.78	40.05	42.29	34.18	27.06
Long-Term Debt	33.09	35.42	35.18	7.95	7.89
Other Long-Term Liabilities	4.69	4.94	5.12	5.77	10.27
Total Long-Term Liabilities	37.78	40.36	40.3	13.72	18.17
Total Liabilities	78.56	80.41	82.59	47.9	45.23
Total Debt	39.14	41.7	38.79	16.15	13.91
Debt Growth	-6.14%	7.49%	140.22%	16.06%	27.34%
Retained Earnings	47.51	28.76	28.02	34.15	37.82
Comprehensive Income	-3.38	-3.44	-3.74	-3.58	-9.6
Shareholders' Equity	54.76	37.41	35.69	41.24	38.42
Net Cash / Debt	-13.2	-27.88	-18.44	-10.42	-8.7
Net Cash Per Share	-4.49	-9.61	-6.62	-3.77	-3.16
Working Capital	56.04	47.87	49.27	26.28	27.17
Book Value Per Share	19.02	13.25	12.81	14.94	13.97

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).